Justin C Brown1,2, Michael O Harhay3, Meera N Harhay4. 1. Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. justinc_brown@dfci.harvard.edu. 2. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. justinc_brown@dfci.harvard.edu. 3. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. 4. Division of Nephrology, Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
Abstract
PURPOSE: We hypothesized that anthropometrically predicted visceral adipose tissue (apVAT) accounts for more variance in blood-based biomarkers of glucose homeostasis, inflammation, and lipid metabolism than body mass index (BMI), waist circumference (WC), and the combination of BMI and WC (BMI + WC). METHODS: This was a cross-sectional analysis of 10,624 males and females who participated in the Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994). apVAT was predicted from a validated regression equation that included age, height, weight, waist, and thigh circumferences. Bootstrapped linear regression models were used to compare the proportion of variance (R 2) in biomarkers explained by apVAT, BMI, WC, and BMI + WC. RESULTS: apVAT accounted for more variance in biomarkers of glucose homeostasis than BMI (∆R 2 = 8.4-11.8 %; P < 0.001), WC (∆R 2 = 5.5-8.4 %; P < 0.001), and BMI + WC (∆R 2 = 5.1-7.7 %; P < 0.001). apVAT accounted for more variance in biomarkers of inflammation than BMI (ΔR 2 = 3.8 %; P < 0.001), WC (ΔR 2 = 3.1 %; P < 0.001), and BMI + WC (ΔR 2 = 2.9 %; P < 0.001). apVAT accounted for more variance in biomarkers of lipid metabolism than BMI (ΔR 2 = 2.9-9.2 %; P < 0.001), WC (ΔR 2 = 2.9-5.2 %; P < 0.001), and BMI + WC (ΔR 2 = 2.4-4.1 %; P ≤ 0.01). CONCLUSIONS: apVAT, estimated with simple and widely used anthropometric measures, accounts for more variance in blood-based biomarkers than BMI, WC, and BMI + WC. Clinicians and researchers may consider utilizing apVAT to characterize cardio-metabolic health, particularly in settings with limited availability of imaging and laboratory data.
PURPOSE: We hypothesized that anthropometrically predicted visceral adipose tissue (apVAT) accounts for more variance in blood-based biomarkers of glucose homeostasis, inflammation, and lipid metabolism than body mass index (BMI), waist circumference (WC), and the combination of BMI and WC (BMI + WC). METHODS: This was a cross-sectional analysis of 10,624 males and females who participated in the Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994). apVAT was predicted from a validated regression equation that included age, height, weight, waist, and thigh circumferences. Bootstrapped linear regression models were used to compare the proportion of variance (R 2) in biomarkers explained by apVAT, BMI, WC, and BMI + WC. RESULTS: apVAT accounted for more variance in biomarkers of glucose homeostasis than BMI (∆R 2 = 8.4-11.8 %; P < 0.001), WC (∆R 2 = 5.5-8.4 %; P < 0.001), and BMI + WC (∆R 2 = 5.1-7.7 %; P < 0.001). apVAT accounted for more variance in biomarkers of inflammation than BMI (ΔR 2 = 3.8 %; P < 0.001), WC (ΔR 2 = 3.1 %; P < 0.001), and BMI + WC (ΔR 2 = 2.9 %; P < 0.001). apVAT accounted for more variance in biomarkers of lipid metabolism than BMI (ΔR 2 = 2.9-9.2 %; P < 0.001), WC (ΔR 2 = 2.9-5.2 %; P < 0.001), and BMI + WC (ΔR 2 = 2.4-4.1 %; P ≤ 0.01). CONCLUSIONS: apVAT, estimated with simple and widely used anthropometric measures, accounts for more variance in blood-based biomarkers than BMI, WC, and BMI + WC. Clinicians and researchers may consider utilizing apVAT to characterize cardio-metabolic health, particularly in settings with limited availability of imaging and laboratory data.
Entities:
Keywords:
Adiposity; Body composition; Population-based; Waist–hip ratio
Authors: I Lemieux; A Pascot; C Couillard; B Lamarche; A Tchernof; N Alméras; J Bergeron; D Gaudet; G Tremblay; D Prud'homme; A Nadeau; J P Després Journal: Circulation Date: 2000-07-11 Impact factor: 29.690
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Sarah Lewington; Gary Whitlock; Robert Clarke; Paul Sherliker; Jonathan Emberson; Jim Halsey; Nawab Qizilbash; Richard Peto; Rory Collins Journal: Lancet Date: 2007-12-01 Impact factor: 79.321
Authors: Karla M Pou; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Pal Maurovich-Horvat; Martin G Larson; John F Keaney; James B Meigs; Izabella Lipinska; Sekar Kathiresan; Joanne M Murabito; Christopher J O'Donnell; Emelia J Benjamin; Caroline S Fox Journal: Circulation Date: 2007-08-20 Impact factor: 29.690
Authors: K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith Journal: Circulation Date: 2009-10-05 Impact factor: 29.690
Authors: Sanjiv Kaul; Megan P Rothney; Dawn M Peters; Wynn K Wacker; Cynthia E Davis; Michael D Shapiro; David L Ergun Journal: Obesity (Silver Spring) Date: 2012-01-26 Impact factor: 5.002
Authors: Lisa K Micklesfield; Julia H Goedecke; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly Journal: Obesity (Silver Spring) Date: 2012-01-12 Impact factor: 5.002
Authors: Nitin Kapoor; Stephen A Jiwanmall; Munaf B Nandyal; Dheeraj Kattula; Sandhiya Paravathareddy; Thomas V Paul; John Furler; Brian Oldenburg; Nihal Thomas Journal: Diabetes Metab Syndr Obes Date: 2020-09-16 Impact factor: 3.168